Naloxone hydrochloride is an opioid inverse agonist compound used to counter the effects of opiate overdose.
|Source||J Pharmacol Exp Ther (2016). Figure 2. Naloxone hydrochloride|
|Cell Lines||C57BL/6J-Bom mice|
|Concentrations||0.01, 0.1, 1, 10, or 50 mg/kg|
|Incubation Time||90 min|
|Results||Mice administered a higher 50-mg/kg (1)-naloxone dose in combination with heroin demonstrated a clear reduction in locomotor activity (41% reduction in maximal distance run), as did mice given this dose of (1)-naloxone in combination with 6-AM|
|Source||J Pharmacol Exp Ther (2016). Figure 1. Naloxone hydrochloride|
|Cell Lines||C57BL/6J-Bom mice|
|Concentrations||0.01, 0.1, or 1 mg/kg|
|Incubation Time||60 min|
|Results||Thereafter, locomotor activity increased until approximately 90 minutes after morphine administration, displaying an almost 40% reduction of the maximal distance run (P,0.01), before it declined. The lowest dose of (2)-naloxone showed no effect on morphine-induced locomotor activity|
|Cell lines||BV‐2 cells|
|Preparation method||The phagocytic activity of BV‐2 cells was measured by Vybrant phagocytosis assay kit according to the manufacturer's instructions. Briefly, BV‐2 cells were treated with LPS (200 ng·mL−1) and (+)‐naltrexone/(+)‐naloxone for 24 h.|
|Incubation time||24 h|
|Animal models||adult male C57BL/6J-Bom mice|
|Dosages||0.01, 0.1, or 1 mg/kg|
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Solubility||DMSO 60 mg/mL|
Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
Eriksen GS, et al. J Pharmacol Exp Ther. 2016 Aug;358(2):209-15. PMID: 27278234.
Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.
Wang X, et al. Br J Pharmacol. 2016 Mar;173(5):856-69. PMID: 26603732.
|Related Opioid Receptor Products|
Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.
Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain.
Docusate Sodium is a laxative used to treat constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally.
Alvimopan dihydrate(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
PZM21 is a potent and selective μ-opioid-receptor (μOR) agonist with an EC50 of 1.8 nM.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.